Photobiomodulation and visual stimulation against cognitive decline and Alzheimer's disease pathology: A systematic review

被引:13
作者
Monteiro, Francisca [1 ,2 ,3 ]
Carvalho, Oscar [1 ,3 ]
Sousa, Nuno [2 ,4 ]
Silva, Filipe S. [1 ,3 ]
Sotiropoulos, Ioannis [2 ,4 ,5 ]
机构
[1] Univ Minho, Ctr Microelectromechan Syst CMEMS, Campus Azurem, P-4800058 Guimaraes, Portugal
[2] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal
[3] Univ Minho, Associate Lab, LABBELS, Guimaraes, Portugal
[4] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Campus Gualtar, P-4710057 Braga, Portugal
[5] NCSR Demokritos, Inst Biosci & Applicat, Athens, Greece
关键词
Alzheimer's disease; cognitive decline; light-based therapies; photobiomodulation; visual stimulation; LEVEL LASER THERAPY; TRANSCRANIAL LED THERAPY; MOUSE MODEL; CELL APOPTOSIS; LIGHT; BRAIN; PROPAGATION; DYSFUNCTION; RESPONSES; STRESS;
D O I
10.1002/trc2.12249
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionGiven the ineffectiveness of the available drug treatment against Alzheimer disease (AD), light-based therapeutic modalities have been increasingly receiving attention with photobiomodulation (PBM) and, more recently, visual stimulation (VS) being among the most promising approaches. However, the PBM and VS light parameters tested so far, as well as their outcomes, vary a lot with conflicting results being reported. MethodsBased on Scopus, PubMed, and Web of Science databases search, this systematic review summarizes, compares, and discusses 43 cell, animal, and human studies of PBM and VS related to cognitive decline and AD pathology. ResultsPreclinical work suggests that PBM with 640 +/- 30-nm light and VS at 40 Hz attenuates A beta and Tau pathology and improves neuronal and synaptic plasticity with most studies pointing towards enhancement of degradation/clearance mechanisms in the brain of AD animal models. Despite the gap of the translational evidence for both modalities, the few human studies performed so far support the use of PBM at 810-870 nm light pulsing at 40 Hz for improving brain network connectivity and memory in older subjects and AD patients, while 40 Hz VS in humans seems to improve cognition; further clinical investigation is urgently required to clarify the beneficial impact of PBM and VS in AD patients. DiscussionThis review highlights PBM and VS as promising light-based therapeutic approaches against AD brain neuropathology and related cognitive decline, clarifying the most effective light parameters for further preclinical and clinical testing and use. HighlightsLight-based brain stimulation produces neural entrainment and reverts neuronal damageBrain PBM and VS attenuate AD neuropathologyPMB and VS are suggested to improve cognitive performance in AD patients and animal modelsLight stimulation represents a promising therapeutic strategy against neurodegeneration
引用
收藏
页数:24
相关论文
共 104 条
  • [11] Altered slow (<1 Hz) and fast (beta and gamma) neocortical oscillations in the 3xTg-AD mouse model of Alzheimer's disease under anesthesia
    Castano-Prat, Patricia
    Perez-Mendez, Lorena
    Perez-Zabalza, Maria
    Sanfeliu, Coral
    Gimenez-Llort, Lydia
    Sanchez-Vives, Maria V.
    [J]. NEUROBIOLOGY OF AGING, 2019, 79 : 142 - 151
  • [12] Photobiomodulation improves the frontal cognitive function of older adults
    Chan, Agnes S.
    Lee, Tsz Lok
    Yeung, Michael K.
    Hamblin, Michael R.
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2019, 34 (02) : 369 - 377
  • [13] Effects of Home Photobiomodulation Treatments on Cognitive and Behavioral Function, Cerebral Perfusion, and Resting-State Functional Connectivity in Patients with Dementia: A Pilot Trial
    Chao, Linda L.
    [J]. PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY, 2019, 37 (03) : 133 - 141
  • [14] Chatterjee S., 2019, FRONT NEUROSCI, V13, P1
  • [15] Toward Understanding How Early-Life Stress Reprograms Cognitive and Emotional Brain Networks
    Chen, Yuncai
    Baram, Tallie Z.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2016, 41 (01) : 197 - 206
  • [16] Photobiomodulation Using a Low-Level Light-Emitting Diode Improves Cognitive Dysfunction in the 5XFAD Mouse Model of Alzheimer's Disease
    Cho, Gwang Moo
    Lee, Seo-Yeon
    Park, Jung Hwa
    Kim, Min Jae
    Park, Kyoung-Jun
    Choi, Byung Tae
    Shin, Yong-Il
    Kim, Nam Gyun
    Shin, Hwa Kyoung
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2020, 75 (04): : 631 - 639
  • [17] Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
    Cirrito, JR
    Yamada, KA
    Finn, MB
    Sloviter, RS
    Bales, KR
    May, PC
    Schoepp, DD
    Paul, SM
    Mennerick, S
    Holtzman, DM
    [J]. NEURON, 2005, 48 (06) : 913 - 922
  • [18] Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies
    Comerota, Michele M.
    Tumurbaatar, Batbayar
    Krishnan, Balaji
    Kayed, Rakez
    Taglialatela, Giulio
    [J]. MOLECULAR NEUROBIOLOGY, 2019, 56 (05) : 3341 - 3355
  • [19] Near infrared light decreases synaptic vulnerability to amyloid beta oligomers
    Comerota, Michele M.
    Krishnan, Balaji
    Taglialatela, Giulio
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [20] De la Torre J.C., 2016, Alzheimers Turning Point: A Vascular Approach to Clinical Prevention